ImmuCell Corporation ICCC
10.18 USD +0.38 (+3.88%)
Nov 9, 2026, 10:44 AM EST
9.94 Day range 10.18
4.52 52-week range 12.10
- YTD
- +65.53%
- 1 year
- +66.89%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 27.64M | 26.49M | 17.47M | 18.57M | 19.24M | |
| 11.45M | 7.94M | 3.87M | 7.65M | 8.66M | |
| 1.65M | -1.64M | -5.75M | -2.30M | 257.38K | |
| -1.04M | -2.16M | -5.77M | -2.49M | -78.29K | |
| -0.12 | -0.26 | -0.75 | -0.32 | -0.01 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.81M | 3.76M | 978.74K | 5.79M | 10.19M | |
| 42.53M | 45.10M | 43.81M | 44.86M | 44.47M | |
| 15.48M | 17.58M | 18.82M | 14.48M | 11.89M | |
| 13.19M | 15.10M | 16.69M | 12.48M | 10.27M | |
| 27.06M | 27.52M | 24.99M | 30.38M | 32.58M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.48M | 357.90K | -4.67M | -1.54M | 954.17K | |
| -1.21M | -461.23K | -1.89M | -3.96M | -1.60M | |
| -1.21M | 2.88M | 1.75M | 1.11M | 3.88M | |
| -1.21M | -461.23K | -1.89M | -3.96M | -2.59M | |
| 48.60K | 2.78M | -4.81M | -4.39M | 3.24M |